Abstract
Neo-adjuvant chemotherapy (NAC) is one of the main treatments in breast cancer, given before surgery to reduce the tumor's size and increase the surgical outcome's success rate. Predicting the response of breast cancer patients to NAC can be challenging, and inaccurate prediction may lead to suboptimal treatment outcomes. Previous studies have shown that machine learning methods based on Magnetic Resonance Imaging (MRI) can be used to predict the response of breast cancer to NAC with promising accuracy. However, data heterogeneity and feature representation dilemmas are still significant challenges. In this paper, we propose a novel framework Deep Broad Learning Maximal Enhancement Projection (DBL-MEP) with two main functional modules, that is, maximal enhancement projection (MEP) maps and deep-broad learning (DBL). Firstly, the framework can transform dynamic contrast enhancement MRI (DCE-MRI) to acquire multi-angle MEP maps, which can reduce the effect of heterogeneity caused by data collected from different centers. Secondly, the framework uses DBL for feature extraction and integration, which can reduce the risk of overfitting by using a diverse set of imaging features. The framework is trained and tested on a large-scale dataset with 1589 breast cancer patients from multiple centers. Extensive experiments demonstrate that the proposed method is superior to traditional method and shows stable performance across different scanners and field strengths. To the best of the authors’ knowledge, this is the first paper to apply deep broad learning techniques and multi-angle enhancement projection maps of DCE-MRI in prediction of treatment response to NAC in breast cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sung, H., Ferlay, J., Siegel, R.L., et al.: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA J. Clin. 71(3), 209–249 (2021)
Korde, L.A., Somerfield, M.R., Carey, L.A., et al.: Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. J. Clin. Oncol. 39(13), 1485–1505 (2021)
Marinovich, M.L., Macaskill, P., Irwig, L., et al.: Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis. BMC Cancer 15(1), 1–12 (2015)
Yee, D., DeMichele, A.M., Yau, C., et al.: Association of event-free and distant recurrence–free survival with individual-level pathologic complete response in neoadjuvant treatment of stages 2 and 3 breast cancer: three-year follow-up analysis for the i-spy2 adaptively randomized clinical trial. JAMA Oncol. 6(9), 1355–1362 (2020)
Symmans, W.F., Yau, C., Chen, Y.Y., et al.: Assessment of residual cancer burden and event-free survival in neoadjuvant treatment for high-risk breast cancer: an analysis of data from the I-SPY2 randomized clinical trial. JAMA Oncol. 7(11), 1654–1663 (2021)
Kim, S.Y., Cho, N., Choi, Y., et al.: Factors affecting pathologic complete response following neoadjuvant chemotherapy in breast cancer: development and validation of a predictive nomogram. Radiology 299(2), 290–300 (2021)
Brackstone, M., Baldassarre, F.G., Perera, F.E., et al.: Management of the axilla in early-stage breast cancer: ontario health (Cancer Care Ontario) and ASCO guideline. J. Clin. Oncol. 39(27), 3056–3082 (2021)
Fayanju, O.M., Ren, Y., Thomas, S.M., et al.: The clinical significance of breast-only and node-only pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT): a review of 20,000 breast cancer patients in the National Cancer Data Base (NCDB). Ann. Surg. 268(4), 591 (2018)
An, J., Peng, C., Tang, H., Liu, X., Peng, F.: New advances in the research of resistance to neoadjuvant chemotherapy in breast cancer. Int. J. Mol. Sci. 22(17), 9644 (2021)
Cardoso, F., Senkus, E., Costa, A., et al.: 4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4)†. Ann. Oncol. 29(8), 1634–1657 (2018). https://doi.org/10.1093/annonc/mdy192
Conti, A., Duggento, A., Indovina, I., Guerrisi, M., Toschi, N.: Radiomics in breast cancer classification and prediction. In: Seminars in Cancer Biology, vol. 72, pp. 238–250 (2021)
Gullo, R.L., Eskreis-Winkler, S., Morris, E.A., Pinker, K.: Machine learning with multiparametric magnetic resonance imaging of the breast for early prediction of response to neoadjuvant chemotherapy. The Breast 49, 115–122 (2020)
Zwanenburg, A., Vallières, M., Abdalah, M.A., et al.: The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295(2), 328–338 (2020)
Shen, D., Wu, G., Suk, H.I.: Deep learning in medical image analysis. Annu. Rev. Biomed. Eng. 19, 221–248 (2017)
Hamidinekoo, A., Denton, E., Rampun, A., Honnor, K., Zwiggelaar, R.: Deep learning in mammography and breast histology, an overview and future trends. Med. Image Anal. 47, 45–67 (2018)
Chen, C.P., Liu, Z.: Broad learning system: an effective and efficient incremental learning system without the need for deep architecture. IEEE Trans. Neural Netw. Learn. Syst. 29(1), 10–24 (2017)
Liu, Z., Zhou, J., Chen, C.P.: Broad learning system: feature extraction based on K-means clustering algorithm. In: 2017 4th International Conference on Information, Cybernetics and Computational Social Systems (ICCSS), pp. 683–687. IEEE (2017)
Gong, X., Zhang, T., Chen, C.P., Liu, Z.: Research review for broad learning system: algorithms, theory, and applications.IEEE Trans. Cybern. (2021)
Feng, S., Chen, C.P.: Fuzzy broad learning system: a novel neuro-fuzzy model for regression and classification. IEEE Trans. Cybern. 50(2), 414–424 (2018)
Leithner, D., Wengert, G.J., Helbich, T.H., et al.: Clinical role of breast MRI now and going forward. Clin. Radiol. 73(8), 700–714 (2018)
Hylton, N.M., Blume, J.D., Bernreuter, W.K., et al.: Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy—results from ACRIN 6657/I-SPY TRIAL. Radiology 263(3), 663–672 (2012)
Michoux, N., Van den Broeck, S., Lacoste, L., et al.: Texture analysis on MR images helps predicting non-response to NAC in breast cancer. BMC Cancer 15, 1–13 (2015). https://doi.org/10.1186/s12885-015-1563-8
Li, Y., Fan, Y., Xu, D., et al.: Deep learning radiomic analysis of DCE-MRI combined with clinical characteristics predicts pathological complete response to neoadjuvant chemotherapy in breast cancer. Front. Oncol. 12, 7319 (2022)
Huang, Y., Zhu, T., Zhang, X., et al.: Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study. EClinicalMedicine 58 (2023)
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Cao, Z. et al. (2023). DBL-MPE: Deep Broad Learning for Prediction of Response to Neo-adjuvant Chemotherapy Using MRI-Based Multi-angle Maximal Enhancement Projection in Breast Cancer. In: Huang, DS., Premaratne, P., Jin, B., Qu, B., Jo, KH., Hussain, A. (eds) Advanced Intelligent Computing Technology and Applications. ICIC 2023. Lecture Notes in Computer Science, vol 14088. Springer, Singapore. https://doi.org/10.1007/978-981-99-4749-2_26
Download citation
DOI: https://doi.org/10.1007/978-981-99-4749-2_26
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-4748-5
Online ISBN: 978-981-99-4749-2
eBook Packages: Computer ScienceComputer Science (R0)